These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10651651)

  • 1. The brave new world--what can we realistically expect to achieve through cancer control early in the new millennium?
    Miller AB
    Chronic Dis Can; 1999; 20(4):139-50. PubMed ID: 10651651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canadian contributions to cancer control.
    Miller AB
    Can J Oncol; 1994 Jan; 4(1):238-42. PubMed ID: 7512409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality from lung cancer and tobacco smoking in Ohio (U.S.): will increasing smoking prevalence reverse current decreases in mortality?
    Tyczynski JE; Berkel HJ
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1182-7. PubMed ID: 15894669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive health care, 1999 update: prevention of oral cancer mortality. The Canadian Task Force on Preventive Health Care.
    Hawkins RJ; Wang EE; Leake JL
    J Can Dent Assoc; 1999 Dec; 65(11):617. PubMed ID: 10859725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer incidence in young adults in Canada: preliminary results of a cancer surveillance project.
    Marrett LD; Frood J; Nishri D; Ugnat AM;
    Chronic Dis Can; 2002; 23(2):58-64. PubMed ID: 12095456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s.
    Karim-Kos HE; de Vries E; Soerjomataram I; Lemmens V; Siesling S; Coebergh JW
    Eur J Cancer; 2008 Jul; 44(10):1345-89. PubMed ID: 18280139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing cancer through tobacco and infection control: how many lives can we save in the next 10 years?
    Strong K; Mathers C; Epping-Jordan J; Resnikoff S; Ullrich A
    Eur J Cancer Prev; 2008 Apr; 17(2):153-61. PubMed ID: 18287873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient and provider priorities for cancer prevention and control: a qualitative study in Mid-Atlantic Latinos.
    O'Malley AS; Rentería-Weitzman R; Huerta EE; Mandelblatt J;
    Ethn Dis; 2002; 12(3):383-91. PubMed ID: 12148710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considerations regarding the present and future roles of colonoscopy in colorectal cancer prevention.
    Rex DK; Eid E
    Clin Gastroenterol Hepatol; 2008 May; 6(5):506-14. PubMed ID: 18455696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimates of cancer incidence in China for 2000 and projections for 2005.
    Yang L; Parkin DM; Ferlay J; Li L; Chen Y
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):243-50. PubMed ID: 15668501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking cessation and lung cancer mortality in a cohort of middle-aged Canadian women.
    Zhang B; Ferrence R; Cohen J; Bondy S; Ashley MJ; Rehm J; Jain M; Rohan T; Miller A
    Ann Epidemiol; 2005 Apr; 15(4):302-9. PubMed ID: 15780778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Priorities for cancer control in Poland.
    Steffen JA
    Cancer Detect Prev; 1993; 17(4-5):533-8. PubMed ID: 8242654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
    Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
    Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do Ashkenazi Jews have a higher than expected cancer burden? Implications for cancer control prioritization efforts.
    Feldman GE
    Isr Med Assoc J; 2001 May; 3(5):341-6. PubMed ID: 11411198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer detection rates, and standardised detection ratios for prevalence screening in the New Zealand breast cancer screening programme.
    Richardson A; Graham P; Brown T; Smale P; Cox B
    J Med Screen; 2004; 11(2):65-9. PubMed ID: 15153320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cancer screening in Japan--a critique from the epidemiological viewpoint].
    Oshima A
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2284-92. PubMed ID: 4073926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population health impact of cancer in Canada, 2001.
    Boswell-Purdy J; Flanagan WM; Roberge H; Le Petit C; White KJ; Berthelot JM
    Chronic Dis Can; 2007; 28(1-2):42-55. PubMed ID: 17953797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention practices and cancer screening among general practitioners in Picardy (France)].
    Ganry O; Boche T
    Bull Cancer; 2004 Oct; 91(10):785-91. PubMed ID: 15556879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospects for cancer control: colorectal cancer.
    Cox B; Sneyd M
    N Z Med J; 2005 Aug; 118(1221):U1632. PubMed ID: 16138170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.